NCT03739827
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors No drug interventions Not Available Not Available recruiting NCT04222413
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT05322187
Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy treatment 2 / 3 unknown_status NCT02339753
Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation treatment 2 unknown_status NCT02564198
A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors treatment 1 completed NCT04944875
Effects of Music and Maternal Voice on Sedation Depth and Sedative Use During Pediatric Magnetic Resonance Imaging. No drug interventions diagnostic Not Available completed NCT03222258
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients No drug interventions Not Available Not Available completed NCT05024331
A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor No drug interventions Not Available Not Available completed NCT02787876
Pegteograstim in Children With Solid Tumors treatment 2 unknown_status NCT05620862
Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors treatment 1 active_not_recruiting NCT03478462
Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma treatment 1 active_not_recruiting NCT03455140
A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) treatment 1 / 2 completed NCT04897321
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) treatment 1 recruiting NCT01853345
iCAT for Recurrent/Refractory/HR Solid Tumors No drug interventions Not Available Not Available completed NCT04483778
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults treatment 1 active_not_recruiting NCT05468359
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients treatment 1 / 2 recruiting NCT02520713
The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study No drug interventions Not Available Not Available active_not_recruiting NCT05151718
Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents No drug interventions Not Available Not Available recruiting NCT04239040
GVAX Plus Checkpoint Blockade in Neuroblastoma treatment 1 active_not_recruiting NCT03618381
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults No drug interventions treatment 1 recruiting NCT03273829
Study of Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children With Relapsed or Refractory Solid Tumors and Leukemias treatment 1 recruiting NCT03609112
Neurocognitive Risks in Children With Solid Tumors No drug interventions Not Available Not Available unknown_status NCT02392793
Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies treatment 1 completed NCT06612645
A Phase 1 Study of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors treatment 1 not_yet_recruiting NCT03837899
Durvalumab and Tremelimumab for Pediatric Malignancies treatment 1 / 2 active_not_recruiting NCT00990912
A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002) treatment 1 / 2 completed NCT06171971
Clinical and Therapeutic Impact of Large Genomic Studies at Diagnosis in Pediatric Solid Cancers No drug interventions Not Available Not Available recruiting NCT02747537
Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan treatment 2 withdrawn NCT01049841
Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors treatment 1 completed NCT01050296
Molecular Analysis Of Solid Tumors No drug interventions Not Available Not Available recruiting NCT05608148
Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors treatment 1 recruiting NCT04773808
Molecular Characterization of Genetic Alterations in Pediatric Solid Tumors No drug interventions Not Available Not Available recruiting NCT06208657
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer treatment 1 / 2 recruiting NCT02624388
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) supportive_care 2 terminated NCT03430752
Comparing the Impact of Cancer on Quality of Life Between Survivors of Childhood Solid Tumors and Leukemia No drug interventions Not Available Not Available completed NCT03445858
Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults treatment 0 completed NCT03585465
Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors treatment 1 / 2 active_not_recruiting NCT01620372
French Childhood Cancer Survivor Study No drug interventions Not Available Not Available recruiting NCT03206021
COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid Tumors treatment 1 completed NCT01670175
Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors treatment 1 completed NCT01919866
Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells No drug interventions treatment 1 / 2 unknown_status NCT03336931
PRecISion Medicine for Children With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT01337544
Haploidentical Stem Cell Transplantation and IL-15 NK Cell Infusion for Paediatric Refractory Solid Tumours No drug interventions treatment 1 / 2 terminated NCT05504772
Precision Medicine for Every Child With Cancer No drug interventions Not Available Not Available recruiting NCT02533895
Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood treatment 1 completed NCT03936465
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer treatment 1 completed NCT06441331
Phase I Trial to Determine the Dose and Evaluate the PK of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors treatment 1 not_yet_recruiting NCT04381221
Observational MyPal-Child Study on the ePRO-based Early Palliative Care Digital System in Paediatric Oncology Patients No drug interventions Not Available Not Available unknown_status NCT03086421
Social Emotional Development in Young Children With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05481502
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors No drug interventions other Not Available recruiting NCT04471961
Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia No drug interventions prevention Not Available recruiting NCT05633719
Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT04485416
Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors supportive_care 1 recruiting NCT06389357
Return to School Adaptation Programme for Children With Cancer No drug interventions supportive_care Not Available enrolling_by_invitation NCT04671901
A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors treatment 2 terminated NCT05042479
Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology. No drug interventions supportive_care Not Available recruiting NCT04899505
Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology No drug interventions Not Available Not Available recruiting NCT03373656
Vaccination for Children of H&O and Their Parents No drug interventions prevention Not Available recruiting NCT03465592
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma treatment 1 / 2 recruiting NCT00898079
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer No drug interventions Not Available Not Available completed NCT02116777
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies treatment 1 / 2 completed NCT01606878
Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma treatment 1 completed NCT02975882
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors treatment 1 active_not_recruiting NCT01725191
Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors treatment 1 completed NCT01445080
Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia treatment 1 / 2 completed NCT02775292
Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1 treatment 1 completed NCT02808650
Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors treatment 1 completed